100
Views
13
CrossRef citations to date
0
Altmetric
Review

Tapentadol immediate release: a new treatment option for acute pain management

, &
Pages 1-9 | Published online: 08 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joana Barbosa, Juliana Faria, Odília Queirós, Roxana Moreira, Félix Carvalho & Ricardo Jorge Dinis-Oliveira. (2016) Comparative metabolism of tramadol and tapentadol: a toxicological perspective. Drug Metabolism Reviews 48:4, pages 577-592.
Read now
Nalini Vadivelu, Alice Kai, Benjamin Maslin, Gopal Kodumudi, Aron Legler & Jack M Berger. (2015) Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 95-105.
Read now

Articles from other publishers (11)

Yingchao Li, Yongjun Wang, Ran Zhang, Cuiru Liu, Yue Wei, Jin Sun, Zhonggui He, Youjun Xu & Tianhong Zhang. (2018) Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Delivery and Translational Research 8:5, pages 1335-1344.
Crossref
Jessie S Channell & Stephan Schug. (2018) Toxicity of tapentadol: a systematic review. Pain Management 8:5, pages 327-339.
Crossref
Flaminia Coluzzi, Robert TaylorJr.Jr., Joseph V. PergolizziJr.Jr., Consalvo Mattia & Robert B. Raffa. (2016) Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering). Brazilian Journal of Anesthesiology (English Edition) 66:3, pages 310-317.
Crossref
Flaminia Coluzzi, Robert TaylorJr.Jr., Joseph V. PergolizziJr.Jr., Consalvo Mattia & Robert B. Raffa. (2016) Orientação para boa prática clínica para opioides no tratamento da dor: os três “Ts” – titulação (teste), ajustes (individualização), transição (redução gradual). Brazilian Journal of Anesthesiology 66:3, pages 310-317.
Crossref
Escarlata López Ramírez, D. M. Muñoz Carmona, J. Contreras Martínez & A. de la Torre Luque. (2016) Tapentadol in the management of opioid-naïve patients with cancer pain. Revista de la Sociedad Española del Dolor 23.
Crossref
Weiwu Pang, Yu-Cheng Liu, Edgard Maboudou, Tom XianXiu Chen, John M. Chois, Cheng-Chun Liao & Rick Sai-Chuen Wu. (2013) Metoclopramide Improves the Quality of Tramadol PCA Indistinguishable to Morphine PCA: A Prospective, Randomized, Double Blind Clinical Comparison. Pain Medicine 14:9, pages 1426-1434.
Crossref
William W. Stoops, Paul E. A. Glaser & Craig R. Rush. (2013) Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users. Psychopharmacology 228:2, pages 255-262.
Crossref
Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Douglas Y. Shapiro & Sandra D. Comer. (2013) A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin ® (non-TRF) in prescription opioid abusers . Addiction 108:6, pages 1095-1106.
Crossref
Paul Renton, Brenda Green, Shawn Maddaford, Suman Rakhit & John S. Andrews. (2012) NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity. ACS Medicinal Chemistry Letters 3:3, pages 227-231.
Crossref
Ali Eman, Serbülent Gökhan Beyaz, Hasan Sağlam & Mustafa Emre Gürcü. (2012) Pain Management in Prostate Cancer. Open Journal of Urology 02:03, pages 164-172.
Crossref
. (2010) Tapentadol Gains More Attention as New Option for Acute Pain. Topics in Pain Management 25:8, pages 12.
Crossref